Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

FDA Drug Application 202806 by NOVARTIS PHARMS CORP

Application Number202806
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan CodeV

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP05/29/2013N36155000 5/29/2013
AP05/29/2013N36157000 5/30/2013
AP05/29/2013N36161000 5/30/2013
AP05/29/2013N36238000 6/7/2013
AP05/29/2013N36239000Office Director Memo 6/7/2013
AP05/29/2013N36459000 7/5/2013
AP012/26/2013SLR38191001 12/30/2013
AP012/26/2013SLR38195001 12/31/2013
AP01/9/2014SE138246002 1/10/2014
AP01/9/2014SE138260002 1/14/2014
AP011/20/2015S44548004 11/20/2015
AP011/20/2015S44562004 11/23/2015
AP06/16/2016SLR46381005 6/21/2016

Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.